- Home
- PGYWW vs FBIOP Comparison
PGYWW vs FBIOP Comparison
Compare PGYWW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGYWW
- FBIOP
- Stock Information
- Founded
- PGYWW 2016
- FBIOP N/A
- Country
- PGYWW United States
- FBIOP United States
- Employees
- PGYWW 527
- FBIOP 101
- Industry
- PGYWW Finance: Consumer Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- PGYWW Finance
- FBIOP Health Care
- Exchange
- PGYWW Nasdaq
- FBIOP Nasdaq
- Market Cap
- PGYWW N/A
- FBIOP N/A
- IPO Year
- PGYWW N/A
- FBIOP N/A
- Fundamental
- Price
- PGYWW $0.54
- FBIOP $7.09
- Analyst Decision
- PGYWW
- FBIOP
- Analyst Count
- PGYWW 0
- FBIOP 0
- Target Price
- PGYWW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- PGYWW 134.3K
- FBIOP N/A
- Earning Date
- PGYWW 02-13-2025
- FBIOP N/A
- Dividend Yield
- PGYWW N/A
- FBIOP N/A
- EPS Growth
- PGYWW N/A
- FBIOP N/A
- EPS
- PGYWW N/A
- FBIOP N/A
- Revenue
- PGYWW $1,032,248,000.00
- FBIOP N/A
- Revenue This Year
- PGYWW N/A
- FBIOP N/A
- Revenue Next Year
- PGYWW N/A
- FBIOP N/A
- P/E Ratio
- PGYWW N/A
- FBIOP N/A
- Revenue Growth
- PGYWW 27.12
- FBIOP N/A
- 52 Week Low
- PGYWW $0.15
- FBIOP N/A
- 52 Week High
- PGYWW $0.23
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- PGYWW 48.55
- FBIOP 30.76
- Support Level
- PGYWW $0.51
- FBIOP $7.10
- Resistance Level
- PGYWW $0.59
- FBIOP $7.51
- Average True Range (ATR)
- PGYWW 0.07
- FBIOP 0.37
- MACD
- PGYWW -0.01
- FBIOP -0.21
- Stochastic Oscillator
- PGYWW 13.71
- FBIOP 3.67
About PGYWW Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.